Navigation Links
First Genetic Cure For Cancer Anchors Provocative New Thriller
Date:6/27/2012

Dallas, TX (PRWEB) June 27, 2012

What would happen if a groundbreaking advance in medicine fell into the hands of a desperate Wall Street executive, hell-bent on taking the company public and turning a huge profit… no matter the cost.

In his newest novel, "Genetic Imperfections", author Steve Hadden deftly guides readers through the high-stakes world of pharmaceutical development while telling the story of a father turned bitter over the loss of his young son to cancer. Rexen Labs is sitting on a gold mine. After years of development, the family-owned pharmaceutical company is finally prepared to begin marketing the biggest drug breakthrough since penicillin, a genetic cure for cancer. With Rexen Labs ready to go public, billions of dollars—and a ten-year-old’s life—hang in the balance.

Asked why he wrote "Genetic Imperfections", Hadden said, “I’m intrigued by how the complexity of the human genome stands in the way of the first genetic cure for cancer and how corporate greed can transform the most well intended people.”

The thriller opens fifteen years ago, after David Wellington abandoned his lucrative banking career and joined Rexsen Labs to save his young son's life. But despite his sacrifices and prayers, he helplessly watches him die. On that day his heart hardens and he embarks on a path of cynicism, materialism and self-indulgence. Now, propelled by the pending FDA approval of CGT, the first genetic cure for the leukemia that killed his son, he's on the verge of becoming Newport Beach's newest billionaire.

But as Wellington watches his life crumble around him and the cure become a curse, he finds himself at rock-bottom for the second time. Trapped between the authorities and the company he helped build, he risks everything to give meaning to his second chance at life and his only chance for love.

"Genetic Imperfections" is a story of tragedy, greed, redemption and love, uniquely packaged in the thriller genre. It is available through Amazon, Kindle, Barnes and Noble, Nook, Apple’s iBooks, Smashwords, Diesel and Kobo. Visit SteveHadden.com for a synopsis and additional information.

Keep an eye out for Hadden’s next book, "Swimming Monkeys", set to be released later in the summer. A cross between Jurassic Park and The Da Vinci Code, Swimming Monkeys is a powerful coming-of-age thriller that examines the on-going struggle between science and religion.

About Steve Hadden
Steve Hadden is the author of "The Sunset Conspiracy", "Genetic Imperfections" and The "Swimming Monkeys" Trilogy. Steve was born in Ohio and has lived across the U.S. including stops in Maryland, Indiana, Pennsylvania, Oklahoma, Wyoming, California, Texas, Connecticut and Colorado. He’s traveled around the world and uses his experience and curiosity about the larger issues we face to bring his thrillers to life. Steve lives in Texas with his wife, CJ, and two Labrador retrievers, Emma and Abby. Visit his website at http://www.stevehadden.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9640958.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
2. Nourish the World! Terra Biotech Receives Thanks and Praise After First Shipment of 10,000 Servings of Nectr Core Vitamin Powder to Orphans in Ghana, Africa
3. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
4. NDIA, NTSA Will Be On Hand At Seventh Annual Capitol Hill Modeling and Simulation Expo, Set To Focus On Homeland Security, First Response
5. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
6. ScaleMatrix Leads the Way Unveiling the Industry’s First Transparent Pricing Tool in Private Cloud Offerings
7. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
8. CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device
9. First experiment at the ALBA synchrotron
10. EPSRC announces first recipients of Fellowships in Manufacturing
11. GeneLink Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of Directors of ... John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, ... leaders responsible for the commercialization of multiple orphan drug indications. Mr. Tilton ...
(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... ... for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in ... understanding disease and testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging ...
(Date:4/27/2016)... , April 27, 2016 MedDay, a ... today announces the appointment of Catherine Moukheibir as Chairman of ... previous Chairman, Jean Jacques Garaud , who contributed to ... is effective immediately. Catherine started her career in ... and London .  She held C-Suite ...
(Date:4/26/2016)... Redwood City, CA (PRWEB) , ... April 26, ... ... company for healthcare, today announced that Ardy Arianpour has joined the company as ... 14 years of experience bringing innovative genomic technologies to market, was most recently ...
Breaking Biology Technology:
(Date:3/14/2016)... 14, 2016 NXTD ) ("NXT-ID" or ... market, announces the airing of a new series of commercials ... of March 21 st .  The commercials will air on ... Squawk on the Street show. --> NXTD ) ... mobile commerce market, announces the airing of a new series ...
(Date:3/10/2016)... 2016   Unisys Corporation (NYSE: UIS ) ... (CBP) is testing its biometric identity solution at the Otay ... to help identify certain non-U.S. citizens leaving the country. ... to help determine the efficiency and accuracy of using biometric ... will run until May 2016. --> the ...
(Date:3/3/2016)... 3, 2016  FlexTech, a SEMI Strategic Association Partner, ... Research & Development, Leadership in Education, and, in a ... 9 th year of the FLEXI Awards and ... individuals from past years . Judging was done ... set of criteria, by a panel of non-affiliated, independent, ...
Breaking Biology News(10 mins):